Business Standard

Bet on these diagnostic stocks for up to 19% return as Covid-19 cases flare

According to the Union Health Ministry data, India recorded 1,03,558 coronavirus infections on Sunday, pushing the nationwide Covid tally to 1.25 crore

Dr Lal Pathlabs, laboratory, tests, Pathology
Premium

Representative image

Avdhut Bagkar Mumbai
Shares of diagnostics companies were in the spotlight on Monday in an otherwise feeble market as India reported its highest-ever daily tally of 1.03 lakh Covid-19 cases. According to the Union Health Ministry data, India recorded 1,03,558 coronavirus infections on Sunday, pushing the nationwide Covid tally to 1.25 crore.

Among individual stocks, Thyrocare Tech and Metropolis Healthcare rose over 4 per cent each, in intra-day deals, while Dr Lal PathLabs gained 3.9 per cent to hit a record high of Rs 2,924.85. In comparison, the benchmark S&P BSE Sensex was trading 2.6 per cent lower, at 11:30 AM. READ

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in